kidney disease
Conditions
Interventions
administration of antibiotic prophylaxis
not administration of antibiotic prophylaxis
Sponsors
Osaka Red Cross Hospital
Kyoto University Hospital Kitano Hospital National Hospital Organization Kyoto Medical Center Kyoto Min-Iren Chuo Hospital Kobe City Medical Center General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who undergo percutaneous renal biopsy
Exclusion criteria
Exclusion criteria: Patients who present with a white blood cell count of >10/high-power field (HPF) on two occasions during the most recent urinalysis (including once within 3 days of the procedure) patients with allergy to cefazolin patients who received antibiotics administration within seven days before renal biopsy patients who were inserted urethral catheters in the day before from 7 days before renal biopsy patients with human immunodeficiency virus infection patients with pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the number of patients with positive urine cultures in 3 or 4 days after renal biopsy (more than 10 to the 5th power colony forming unit/ml) , or when the patient is diagnosed with pyelonephritis within two or three days after renal biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| the number of patients who had a diagnosis of pyelonephritis within 30 days after renal biopsy the number of patients that who had a diagnosis of puncture site infection within 30 days after renal biopsy the number of patients who had a diagnosis of the infection except pyelonephritis and puncture site infection within 30 days after renal biopsy the number of patients who caused the side effect of antibiotic prophylaxis | — |
Countries
Japan
Contacts
Public ContactKensei Yahata
Osaka Red Cross Hospital Department of Nephrology
Outcome results
None listed